These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Low-molecular-weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting. London NJ; Varty K; Thompson M; Sayers RD; Bell PR Lancet; 1994 Dec; 344(8936):1571-2. PubMed ID: 7848483 [No Abstract] [Full Text] [Related]
23. Femoropopliteal bypass vs percutaneous transluminal angioplasty and stenting in treatment of peripheral artery diseases of infrainquinal segment - short-term results. Cvetanovski MV; Jovev S; Cvetanovska M; Blazevski B; Colanceski R; Andreevska T; Gramatnikovski N; Kartalov A Prilozi; 2009 Jul; 30(1):105-18. PubMed ID: 19736534 [TBL] [Abstract][Full Text] [Related]
24. Aspirin usage and its influence on femoro-popliteal vein graft patency. The Femoro-popliteal Bypass Trial Participants. Franks PJ; Sian M; Kenchington GF; Alexander CE; Powell JT Eur J Vasc Surg; 1992 Mar; 6(2):185-8. PubMed ID: 1572459 [TBL] [Abstract][Full Text] [Related]
25. Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts. A double-blind, placebo-controlled, randomized trial. Rajah SM; Salter MC; Donaldson DR; Subba Rao R; Boyle RM; Partridge JB; Watson DA J Thorac Cardiovasc Surg; 1985 Sep; 90(3):373-7. PubMed ID: 3897722 [TBL] [Abstract][Full Text] [Related]
26. Results of femoropopliteal and femorotibial greater saphenous vein in situ bypass. Life table analysis. Gruss JD; Hiemer W Int Angiol; 1992; 11(2):94-105. PubMed ID: 1402221 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and pharmacodynamics of the antiplatelet combination aspirin (acetylsalicylic acid) plus extended-release dipyridamole are not altered by coadministration with the potent CYP2C19 inhibitor omeprazole. Offman E; Schobelock MJ; Brickl R; VanderMaelen CP; Ehrlich J; Eisert W Am J Cardiovasc Drugs; 2013 Apr; 13(2):113-20. PubMed ID: 23532686 [TBL] [Abstract][Full Text] [Related]
28. Effect of the cyclo-oxygenase inhibitor indobufen on platelet accumulation in prosthetic vascular grafts. Lane IF; Irwin JT; Jennings SA; Poskitt KR; Meek AC; McCollum CN Br J Surg; 1986 Jul; 73(7):563-5. PubMed ID: 3730789 [TBL] [Abstract][Full Text] [Related]
29. Reocclusion prophylaxis with dipyridamole combined with acetylsalicylic acid following PTA. Heiss HW; Just H; Middleton D; Deichsel G Angiology; 1990 Apr; 41(4):263-9. PubMed ID: 2140251 [TBL] [Abstract][Full Text] [Related]
30. Platelet inhibitory drugs: an in vivo method of evaluation in patients. Norcott HC; Goldman M; Hawker RJ; Rafiqi EI; Drolc Z; McCollum CN Thromb Haemost; 1982 Dec; 48(3):307-10. PubMed ID: 6761890 [TBL] [Abstract][Full Text] [Related]
31. The effect of ibustrin on early aortocoronary bypass patency. Pirk J; Rohn V; Peregrin J Cor Vasa; 1990; 32(3):258-62. PubMed ID: 2209029 [TBL] [Abstract][Full Text] [Related]
32. Influence of indobufen on occlusion of arteriovenous fistulas and some platelet activity in intermittent peritoneal dialysis patients. Dmoszyńska A; Janicki K; Janicka L; Przesmycki K; Sokołowska B; Walter-Croneck A Pol J Pharmacol; 1996; 48(3):327-9. PubMed ID: 9112671 [TBL] [Abstract][Full Text] [Related]
33. Does 111indium-platelet deposition predict patency in prosthetic arterial grafts? Goldman M; Hall C; Dykes J; Hawker RJ; McCollum CN Br J Surg; 1983 Oct; 70(10):635-8. PubMed ID: 6414571 [TBL] [Abstract][Full Text] [Related]
34. Effect of antiplatelet and anticoagulant therapy on patency of femorotibial bypass grafts. Ala-Kulju K; Ketonen P; Salo J; Sipponen J; Verkkala K; Harjola PT J Cardiovasc Surg (Torino); 1990; 31(5):651-5. PubMed ID: 2229166 [TBL] [Abstract][Full Text] [Related]
35. Low-dose aspirin combined with dipyridamole versus anticoagulants after femoropopliteal percutaneous transluminal angioplasty. Do DD; Mahler F Radiology; 1994 Nov; 193(2):567-71. PubMed ID: 7972781 [TBL] [Abstract][Full Text] [Related]
36. [Earlier experiences with duplex scanning of femoropopliteal and crural vein bypass]. Nielsen TG; von Jessen F; Schroeder TV Ugeskr Laeger; 1993 Mar; 155(12):881-4. PubMed ID: 8480386 [TBL] [Abstract][Full Text] [Related]
37. Failure of combined acetylsalicylic acid and dipyridamole to prevent occlusion of aortocoronary venous bypass graft. Thaulow E; Frøysaker T; Dale J; Vatne K Scand J Thorac Cardiovasc Surg; 1987; 21(3):215-20. PubMed ID: 3501902 [TBL] [Abstract][Full Text] [Related]
38. Definition of acetylsalicylic acid resistance using whole blood impedance aggregometry in patients undergoing coronary artery surgery. Petricević M; Biocina B; Konosić S; Burcar I; Sirić F; Mihaljević MZ; Ivancan V; Svetina L; Gasparović H Coll Antropol; 2013 Sep; 37(3):833-9. PubMed ID: 24308225 [TBL] [Abstract][Full Text] [Related]
39. [Platelet aggregation inhibitory therapy in chronic arterial occlusive disease of the lower limbs: results of short-term clinico-instrumental study with indobufen]. Landini G; Poggiali C; Calacoci S; Marino N; Rosselli A Recenti Prog Med; 1989 Apr; 80(4):204-7. PubMed ID: 2762658 [TBL] [Abstract][Full Text] [Related]
40. Comparative evaluation of stretch and non-stretch polytetrafluorethylene (PTFE) prosthetic grafts for femoro-popliteal bypass. Lu CH; Chang J; Lai ST; Shih CC Zhonghua Yi Xue Za Zhi (Taipei); 2002 May; 65(5):200-4. PubMed ID: 12166763 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]